Medical Director (m/f/x)

Permanent employee, Full-time · Gräfelfing, New York

Your mission

We are looking for an experienced and strategic Medical Director (m/f/x) to provide medical leadership for a mature global Phase 3 program in relapsing Multiple Sclerosis. In this role, you will combine deep strategic understanding of MS clinical outcomes with hands‑on medical monitoring expertise to support the successful execution of a registrational study, evaluating safety and efficacy.

Clinical Strategy & Leadership: Lead the unblinding, data review, and readout of two Phase 3 clinical trials in relapsing MS, including comprehensive data analysis and interpretation. Provide medical leadership for Clinical Study Reports.
Regulatory Interactions: Support and participate in pre‑NDA regulatory activities (FDA, EMA), ensuring clear communication of clinical outcomes and study rationale.
Scientific Expertise & External Engagement: Collaborate closely with the medical advisory board and key investigators, and represent the program at scientific and medical conferences.
Cross‑Functional Collaboration: Work with our NDA preparation team to shape key messages, clinical summaries, and data presentations across NDA modules.
Data Interpretation: Evaluate high‑level Phase 3 results to support global registration, reimbursement strategies, and scientific publications.
Medical Trial Oversight: Provide hands‑on medical monitoring for the ongoing Phase 3 trial, including review activities during data cleaning.
Pharmacovigilance Support: Partner with the Pharmacovigilance team on medical assessment of safety cases, including review and preparation of narratives for serious adverse events (SAEs).
Leadership in Regulatory Interactions: Serve as a medical leader in planned interactions with regulatory authorities, ensuring alignment on clinical evidence and program strategy.

Your profile

Medical Degree (MD), ideally with training or clinical background in neurology, or advanced degree in science or related field.
3-5+ years of experience in biotech or pharma industry or in academic clinical research within late-stage trials.
Previous involvement in Phase 3 clinical trials is required.
Expertise in Multiple Sclerosis, with scientific understanding of disease mechanisms and clinical development pathways of advantage.
Solid knowledge of Good Clinical Practice (GCP) and international regulatory requirements (FDA, EMA).
Experience in assesing risks, opportunities, and implications in late-stage drug development.
Ability to lead and collaborate effectively in cross-functional and matrix team structures.
Excellent communication skills and a strategic mindset.
Native-level English proficiency.

Why us?

We offer

A permanent position in an international and highly motivated team.
A dynamic, flexible and innovative working environment.
Participation in our company’s success through our stock option program.
Competitive compensation, comprehensive benefits and opportunities for professional growth.
Further benefits that promote our employee’s health and well-being: Wellpass, OpenUp, and more.

Join us and be part of a company where your work directly contributes to our mission of improving
patient care through groundbreaking research. Immunic AG offers a stimulating work environment where
innovation and collaboration are valued.

Apply for this job

About us

Immunic Therapeutics is a dynamic biotechnology company with a pipeline of selective, orally available immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Currently, three small molecule product candidates are in various stages of clinical development. For more information, please visit: www.imux.com.

Apply for this job

We are looking forward to hearing from you!

Thank you for your interest in Immunic AG. Please fill out the following short form. Should you have difficulties with the upload of your data, please send an email to jobs@imux.com.